Suchitra Rao

Dr. Suchitra Rao


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2022 in JAMA Pediatrics
Verified
Journal Article
Open access
PDF file
SRSuchitra Rao
Suchitra Rao
GLGrace M. Lee
Grace M. Lee
HRHanieh Razzaghi
Hanieh Razzaghi
VLVitaly Lorman
Vitaly Lorman
AMAsuncion Mejias
Asuncion Mejias
CFChristopher B. Forrest
Christopher B. Forrest
Scientific and clinical evidence is evolving on the sequelae following COVID-19 caused by SARS-CoV-2. Postacute sequelae of SARS-CoV-2 infection (PASC) has a broad spectrum of clinical manifestations that can affect multiple organ systems. The National Institutes of Health definition of PASC refers to ongoing, relapsing, or new symptoms or other health effects occurring after the acute phase of SARS-CoV-2 infection that is present 4 or more weeks after the acute infection.1 As defined by the US Centers for Disease Control and Prevention, post–COVID-19 conditions include a wide range of new, recurring, or persistent health problems people experience 4 or more weeks after being infected with SARS-CoV-2.2 Alternatively, the World Health Organization defines post–COVID-19 conditions as those occurring 3 or more months from the onset of SARS-CoV-2 infection that cannot be explained by an alternative diagnosis and last for at least 2 months, acknowledging that a separate definition may be applicable for children.3

7 February 2024 in Pediatrics
Verified
Journal Article
Open access
PDF file
SRSuchitra Rao
Suchitra Rao
RGRachel S. Gross
Rachel S. Gross
SMSindhu Mohandas
Sindhu Mohandas
CSCheryl R. Stein
Cheryl R. Stein
ACAbigail Case
Abigail Case
MSMelissa S. Stockwell
Melissa S. Stockwell
The coronavirus disease 2019 (COVID-19) pandemic has caused significant medical, social, and economic impacts globally, both in the short and long term. Although most individuals recover within a few days or weeks from an acute infection, some experience longer lasting effects. Data regarding the postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection (PASC) in children, or long COVID, are only just emerging in the literature. These symptoms and conditions may reflect persistent symptoms from acute infection (eg, cough, headaches, fatigue, and loss of taste and smell), new symptoms like dizziness, or exacerbation of underlying conditions. Children may develop conditions de novo, including postural orthostatic tachycardia syndrome, myalgic encephalomyelitis/chronic fatigue syndrome, autoimmune conditions and multisystem inflammatory syndrome in children. This state-of-the-art narrative review provides a summary of our current knowledge about PASC in children, including prevalence, epidemiology, risk factors, clinical characteristics, underlying mechanisms, and functional outcomes, as well as a conceptual framework for PASC based on the current National Institutes of Health definition. We highlight the pediatric components of the National Institutes of Health-funded Researching COVID to Enhance Recovery Initiative, which seeks to characterize the natural history, mechanisms, and long-term health effects of PASC in children and young adults to inform future treatment and prevention efforts. These initiatives include electronic health record cohorts, which offer rapid assessments at scale with geographical and demographic diversity, as well as longitudinal prospective observational cohorts, to estimate disease burden, illness trajectory, pathobiology, and clinical manifestations and outcomes.

1 July 2023 in JAMA Pediatrics
Verified
Journal Article
Open access
PDF file
SRSuchitra Rao
Suchitra Rao
IAIsaac Armistead
Isaac Armistead
KMKevin Messacar
Kevin Messacar
NANisha B. Alden
Nisha B. Alden
ESEmma Schmoll
Emma Schmoll
SDSamuel R. Dominguez
Samuel R. Dominguez
Respiratory syncytial virus (RSV) experienced a global resurgence 2 years into the COVID-19 pandemic, with record-breaking hospitalization rates in young children.1 Differences in children hospitalized with RSV during the current period (2022-2023) compared with periods prior to COVID-19 remain unclear. In this analysis, we compared age distributions and disease severity in children hospitalized with RSV in Colorado between 2018 and 2023.

1 June 2015 in The Journal of Pediatrics
Verified
Journal Article
Closed access
SRSuchitra Rao
Suchitra Rao
MAMark J. Abzug
Mark J. Abzug
PCPhyllis Carosone-Link
Phyllis Carosone-Link
TPTori Peterson
Tori Peterson
JCJason Child
Jason Child
ESEric A.F. Simões
Eric A.F. Simões

1 June 2021 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
SRSuchitra Rao
Suchitra Rao
MLMolly M. Lamb
Molly M. Lamb
AMAngela Moss
Angela Moss
RMRakesh D. Mistry
Rakesh D. Mistry
KGKathleen Grice
Kathleen Grice
SDSamuel R. Dominguez
Samuel R. Dominguez
Acute respiratory infections represent one of the most common reasons for pediatric emergency department (ED) and urgent care visits.1 It is estimated that in pediatric ED and urgent care settings, 55% to 57% of children are prescribed an antibiotic,2 despite the source of the infection mostly being viral.3 Unnecessary antibiotic prescribing can lead to adverse drug events,4 increased health care costs,5 and antibiotic resistance.6 Identification of the respiratory pathogen provides an opportunity to guide the evaluation and management of children with acute respiratory infection, with the potential to decrease antibiotic use, resource use, and health care costs.7-12

9 November 2015 in Journal of the Pediatric Infectious Diseases Society
Verified
Journal Article
Open access
PDF file
SRSuchitra Rao
Suchitra Rao
BEBenjamin Elkon
Benjamin Elkon
KFKelly B. Flett
Kelly B. Flett
AMAngela F. D. Moss
Angela F. D. Moss
TBTimothy J. Bernard
Timothy J. Bernard
KWKaren M. Wilson
Karen M. Wilson
Factors associated with poor outcomes of children with encephalitis are not well known. We sought to determine whether electroencephalography (EEG) findings, magnetic resonance imaging (MRI) abnormalities, or the presence of seizures at presentation were associated with poor outcomes. A retrospective review of patients aged 0 to 21 years who met criteria for a diagnosis of encephalitis admitted between 2000 and 2010 was conducted. Parents of eligible children were contacted and completed 2 questionnaires that assessed current physical and emotional quality of life and neurological deficits at least 1 year after discharge. During the study period, we identified 142 patients with an International Classification of Diseases 9th Revision diagnosis of meningitis, meningoencephalitis, or encephalitis. Of these patients, 114 met criteria for a diagnosis of encephalitis, and 76 of these patients (representing 77 hospitalizations) had complete data available. Forty-nine (64%) patients were available for follow-up. Patients admitted to the intensive care unit were more likely to have abnormal EEG results (P = .001). The presence of seizures on admission was associated with ongoing seizure disorder at follow-up. One or more years after hospitalization, 78% of the patients had persistent symptoms, including 35% with seizures. Four (5%) of the patients died. Abnormal MRI findings and the number of abnormal findings on initial presentation were associated with lower quality-of-life scores. Encephalitis leads to significant morbidity and death, and incomplete recovery is achieved in the majority of hospitalized patients. Abnormal EEG results were found more frequently in critically ill children, patients with abnormal MRI results had lower quality-of-life scores on follow-up, and the presence of seizures on admission was associated with ongoing seizure disorder and lower physical quality-of-life scores.